CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands | Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | AOCI Attributable to Parent [Member] | Total |
Beginning balance, value at Sep. 30, 2021 | $ 342 | $ 39,257 | $ (3,572) | $ 89 | $ 36,116 |
Common Stock, Shares, Outstanding, Beginning Balance at Sep. 30, 2021 | 3,415,643 | | | | |
Stock-based compensation | $ 0 | 109 | 0 | 0 | 109 |
Exercise of stock options | $ 4 | 311 | 0 | 0 | 315 |
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | 46,377 | | | | |
Director grant | $ 2 | 154 | 0 | 0 | 156 |
Stock Issued During Period, Shares, Issued for Services | 18,900 | | | | |
cash dividends | $ 0 | 0 | (12,808) | 0 | (12,808) |
Expired stock options | | | | 0 | 0 |
Net income | 0 | 0 | 5,949 | 0 | 5,949 |
Unrealized investment gains, net | 0 | 0 | 0 | (3) | (3) |
Ending balance, value at Mar. 31, 2022 | $ 348 | 39,831 | (10,431) | 86 | 29,834 |
Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2022 | 3,480,920 | | | | |
Beginning balance, value at Dec. 31, 2021 | $ 343 | 39,425 | (9,941) | 89 | 29,916 |
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2021 | 3,431,896 | | | | |
Stock-based compensation | $ 0 | 52 | 0 | 0 | 52 |
Exercise of stock options | $ 3 | 200 | 0 | 0 | 203 |
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | 30,124 | | | | |
Director grant | $ 2 | 154 | 0 | 0 | 156 |
Stock Issued During Period, Shares, Issued for Services | 18,900 | | | | |
Net income | $ 0 | 0 | (490) | 0 | (490) |
Unrealized investment gains, net | 0 | 0 | 0 | (3) | (3) |
Ending balance, value at Mar. 31, 2022 | $ 348 | 39,831 | (10,431) | 86 | 29,834 |
Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2022 | 3,480,920 | | | | |
Beginning balance, value at Sep. 30, 2022 | $ 348 | 39,958 | (9,190) | 71 | $ 31,187 |
Common Stock, Shares, Outstanding, Beginning Balance at Sep. 30, 2022 | 3,484,004 | | | | 3,484,004 |
Stock-based compensation | $ 0 | 84 | 0 | 0 | $ 84 |
Exercise of stock options | $ 2 | 125 | 0 | 0 | 127 |
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | 17,285 | | | | |
Director grant | $ 3 | 194 | 0 | 0 | 197 |
Stock Issued During Period, Shares, Issued for Services | 25,200 | | | | |
Expired stock options | $ 0 | (10) | 0 | 0 | (10) |
Net income | 0 | 0 | 960 | 0 | 960 |
Unrealized investment gains, net | 0 | 0 | 0 | 6 | 6 |
Ending balance, value at Mar. 31, 2023 | $ 353 | 40,351 | (8,230) | 77 | $ 32,551 |
Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2023 | 3,526,489 | | | | 3,526,489 |
Beginning balance, value at Dec. 31, 2022 | $ 350 | 40,118 | (8,705) | 75 | $ 31,838 |
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2022 | 3,501,289 | | | | |
Stock-based compensation | $ 0 | 39 | 0 | 0 | 39 |
Exercise of stock options | | | | 0 | 0 |
Director grant | $ 3 | 194 | 0 | 0 | 197 |
Stock Issued During Period, Shares, Issued for Services | 25,200 | | | | |
Net income | $ 0 | 0 | 475 | 0 | 475 |
Unrealized investment gains, net | 0 | 0 | 0 | 2 | 2 |
Ending balance, value at Mar. 31, 2023 | $ 353 | $ 40,351 | $ (8,230) | $ 77 | $ 32,551 |
Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2023 | 3,526,489 | | | | 3,526,489 |